In Parlow's trial, patients received I.V. diphenhydrinate 50mg and if symptoms persisted they were administered I.V. prochloperazine 10mg and ondansetron 4mg.
En el estudio de Parlow, difenhidrinato 50mg intravenoso y, si persistían los síntomas, procloperazina 10mg y ondansetrón 4mg intravenoso.